Investment consortium nears deal for Syneos Health - sources
...By Anirban Sen
NEW YORK (Reuters) - A consortium comprising... risen over 20% since Reuters first reported…
40,900€
0,49%
Echtzeit-Aktienkurs Syneos Health
Bid:
Ask:
Nachrichten zur Syneos Health Aktie
Syneos Health’s stock soars 19% on acquisition report
Syneos Health Inc.’s SYNH stock surged 19% in extended trading Tuesday on a Bloomberg report that a consortium of Elliott…
Syneos Health Hires Finance Chief From Clario
Syneos Health Hires Finance Chief From Clario...…
Syneos Health Schedules First Quarter 2023 Earnings Call for Wednesday, May 10th, 2023
MORRISVILLE, N.C., April 13, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), a leading fully integrated biopharmaceutical solutions organization,…
Syneos Health gains on report of private equity interest
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Syneos Health Wins 2023 ViE Award
Company Recognized for Positive Vaccine Expertise Contributions Company Recognized for Positive Vaccine Expertise Contributions...…
Syneos Health names interim CFO
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Syneos Health Names Stanford Rudnick Interim Finance Chief >SYNH
Syneos Health Names Stanford Rudnick Interim Finance Chief >SYNH...…
Form 8-K Syneos Health, Inc. For: Mar 27
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Syneos Health Launches Medical Affairs Digital Amplifier
Program Drives Digital and Omnichannel Engagement for Medical Science Liaison Teams & Medical Conferences Program Drives Digital and Omnichannel Engagement…
Syneos Health (SYNH) Partners With KX for Data-Driven Insights
Syneos Healths (SYNH) partnership with KX is likely to accelerate clinical trial execution using AI-enabled solutions....…
Syneos Health and KX Partner to Pioneer Data-Driven Transformation in Biopharmaceutical Asset Development
Collaboration Will Leverage Data Analytics and AI to Accelerate Clinical Trial Execution Collaboration Will Leverage Data Analytics and AI to…
Syneos Health inks deal with Microsoft to further use AI
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Syneos Health Collaborates with Microsoft to Accelerate AI Across the Clinical to Commercial Continuum
Collaboration Leverages AI-ready Technology to Speed Asset Development and Optimize Performance Collaboration Leverages AI-ready Technology to Speed Asset Development and…
Syneos Health may be worth between $40-$53 a share in a sale - analyst
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Syneos Health Unveils New Decentralized Clinical Trial Site Network to Drive DCT Adoption
Newly Established Network Will Enable High Quality DCTs & Digital Health Technology Solutions Newly Established Network Will Enable High Quality DCTs…
EXCLUSIVE-Syneos Health eyes sale of company as contract backlog shrinks-sources
... (Reuters) - Syneos Health Inc is making
a new effort to sell itself after..., according to people
familiar with the matter.
Reuters…
Syneos Health (SYNH) Q4 Earnings Beat Estimates, Margins Down
Higher reimbursable expenses and growth in Deployment Solutions contribute to Commercial Solutions revenue growth at Syneos Health (SYNH)....…
Is Syneos Health (SYNH) On The Mend?
Shares of Syneos Health (SYNH) gained more than 9% today after the company reported better-than-expected results for the final quarter…
Syneos Health Non-GAAP EPS of $1.23 beats by $0.03, revenue of $1.36B beats by $80M
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Syneos Health ticks higher amid activist speculation after 13F filing
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Syneos Health falls as JPMorgan downgrades ahead of earnings
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Earnings Preview: Syneos Health (SYNH) Q4 Earnings Expected to Decline
Syneos Health (SYNH) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its…
Syneos Health Schedules Fourth Quarter and Full Year 2022 Earnings Call for Thursday, February 16th, 2023
MORRISVILLE, N.C., Feb. 08, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization,…
Syneos Health joins hand with Equicare to accelerate clinical trial reserach
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Syneos Health Partners with Equicare, Optimizing Data Capture and Integration to Accelerate Clinical Trial Research
MORRISVILLE, N.C., Feb. 08, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization,…
Syneos Health and Haystack Health Partner to Accelerate Clinical Trials with AI
Combined Capabilities Will Help Improve Trial Lifecycles for Patients, Sites & Sponsors Combined Capabilities Will Help Improve Trial Lifecycles for…
Implied Volatility Surging for Syneos Health (SYNH) Stock Options
Investors need to pay close attention to Syneos Health (SYNH) stock based on the movements in the options market lately....…
Expert Ratings for Syneos Health
Latest Ratings for SYNH
DateFirmActionFromTo Mar 2022MizuhoMaintainsBuy Jan 2022BarclaysMaintainsOverweight Dec 2021CitigroupDowngradesBuyNeutral
View More Analyst Ratings…
Syneos Health (SYNH) to Launch Serplulimab With New Pact
Syneos Healths (SYNH) new partnership will develop an advanced commercialization model to serve healthcare professionals and patients in the best…
Syneos Health Announces Partnership with Fosun Pharma USA to Launch Serplulimab
Relationship Will Leverage Syneos One Expertise, Accessing Clinical and Commercial Solutions Relationship Will Leverage Syneos One Expertise, Accessing Clinical and…
Syneos Health CFO Meggs to leave company
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Syneos Health Announces Chief Financial Officer Transition
Reaffirms Full-Year 2022 Revenue Guidance Reaffirms Full-Year 2022 Revenue Guidance...…
Syneos Health to Present at the 41st Annual J.P. Morgan Healthcare Conference
MORRISVILLE, N.C., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization,…